CELEX: 22020D0821
Language: en
Date: 2019-03-29 00:00:00
Title: Decision of the EEA Joint Committee No 68/2019 of 29 March 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/821]

2.7.2020   
               
               
                  EN
               
               
                  Official Journal of the European Union
               
               
                  L 210/34
               
            
         DECISION OF THE EEA JOINT COMMITTEE No 68/2019
         of 29 March 2019
         amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2020/821]
         THE EEA JOINT COMMITTEE,
         Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
         Whereas:
         
                     (1)
                  
                  
                     Commission Implementing Regulation (EU) 2018/1292 of 25 September 2018 approving cyphenothrin as an existing active substance for use in biocidal products of product-type 18 (1) is to be incorporated into the EEA Agreement.
                  
               
                     (2)
                  
                  
                     Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms and conditions of the authorisation of a biocidal product family containing deltamethrin referred by Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement.
                  
               
                     (3)
                  
                  
                     Annex II to the EEA Agreement should therefore be amended accordingly,
                  
               HAS ADOPTED THIS DECISION:
         
            Article 1
            The following points are inserted after point 12zzzzzs (Commission Implementing Decision (EU) 2018/1623) of Chapter XV of Annex II to the EEA Agreement:
            
                        ‘12zzzzzt.
                     
                     
                        
                           32018 R 1292: Commission Implementing Regulation (EU) 2018/1292 of 25 September 2018 approving cyphenothrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 241, 26.9.2018, p. 11).
                     
                  
                        12zzzzzu.
                     
                     
                        
                           32018 D 1305: Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms and conditions of the authorisation of a biocidal product family containing deltamethrin referred by Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 244, 28.9.2018, p. 109).’
                     
                  
         
            Article 2
            The texts of Implementing Regulation (EU) 2018/1292 and of Implementing Decision (EU) 2018/1305 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
         
         
            Article 3
            This Decision shall enter into force on 30 March 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
         
         
            Article 4
            This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
         
         
            Done at Brussels, 29 March 2019.
            
               
                  For the EEA Joint Committee
               
               
                  The President
               
               Claude MAERTEN
            
         
         
            (1)  OJ L 241, 26.9.2018, p. 11.
         
            (2)  OJ L 244, 28.9.2018, p. 109.
         
            (*1)  No constitutional requirements indicated.